Gavi and the Global Fund

Debate between Monica Harding and Iqbal Mohamed

Thursday 15th May 2025 Westminster Hall

[Monica Harding (Esher and Walton) (LD)]

It is an honour to serve under your chairship, Ms Jardine, and I congratulate the hon. Member for Milton Keynes Central (Emily Darlington) on securing this debate. This year, as both Gavi, the Vaccine Alliance, and the Global Fund conduct their funding replenishments, it is more important than ever that we consider the indispensable value of their work, both for Britain and the world. Since its inception at the beginning of the millennium, Gavi has immunised more than 1 million children and saved in the region of 20 million lives.

The UK was one of the alliance’s founders and has since constituted its largest single sovereign donor. In its short existence, the Global Fund has succeeded in driving down the death rates across AIDS, TB and malaria by 61%, saving 65 million lives. That is close to the entire population of this country and would not have been achieved without British support. That manifested most recently in a £1 billion pledge to the Global Fund’s seventh replenishment. That money is likely to avert around 1 million deaths. We have made so much progress, eliminating many diseases in some countries and reaching the edge of success in others.

However, the work of Gavi and the Global Fund is being placed at risk by short-sighted cuts to international development spending. President Trump has gutted USAID, shattered the fund that fights HIV and AIDS and is poised to eliminate much American funding for global immunisation efforts. Following that playbook, this Government have decided to slash British development spending to 0.3% of our GNI, its lowest level this century.

I, like many others, still remember the optimism of the last Labour Government, who pledged to make poverty history and funded Gavi and the Global Fund when they were created. This Government have rejected so much of the proud 1997 legacy, and they must not do so when it comes to global health. I hope that they put money behind their pledge to prioritise global health and vaccinations. There are so many strong and resonant moral arguments for Britain, but at the same time, the fight against disease serves concrete British interests.

The war against infection is currently facing an alignment of factors that make victory more challenging than ever. Climate change is amplifying disease risk. Higher temperatures are opening up regions to mosquitoes, and the incidence of dangerous weather conditions is on the rise. Pakistan’s catastrophic 2022 floods, for example, have since led to almost 7 million additional malaria cases. At the same time, the disturbing spread and intensification of conflict across the globe is impeding efforts to treat and prevent disease. Increasingly, civilian populations are being deliberately cut off from aid, while healthcare facilities are being not only disrupted, but targeted. Consequently, we are seeing the return of once-controlled diseases like polio and upticks in those like cholera, which emerge from degraded sanitary infrastructure.

Why does this matter for Britain? It is because, as we have heard, disease does not respect borders. Since covid, we are all only too aware that disease can reach our shores, putting both our NHS and our health security at risk. Resistance, particularly in strains of TB and malaria, is also an increasing threat. Both Gavi and the Global Fund are working on the development and deployment of new generations of TB vaccines, even in the face of these new headwinds. Existing interventions for fighting malaria are also seeing their efficacy decline in the face of insecticide and drug resistance. Better, sharper tools have been developed. The challenge now is getting them to where they are needed, and for that we need the Global Fund.

[Iqbal Mohamed]

Before I came to this place, I worked in the pharmaceutical industry in safety, efficacy and regulatory compliance. Does the hon. Member agree that the leadership role that the UK has played to date is not just limited to financial contributions and support, but has ensured that the vaccines that are rolled out in third world and low and middle-income countries are as safe as they can be?